Proto Script Pharmaceutical CorpOver The Counter Market:PSCR
- LAST PRICE0.0002
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close--- / 0.0002
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Proto Script Pharmaceutical Corp | 9.8K | 0.0x | --- |
Renewal Fuels Inc | 2.6K | 0.0x | --- |
3Dshopping.Com | 10.0 | 0.0x | --- |
KMA Global Solutions International Inc | 610.0 | --- | --- |
Signature Leisure Inc | 400.0 | 0.0x | --- |
Lixiang Education Holding Co Ltd | 2.5M | 0.0x | --- |
Company Information
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Contact Information
- Headquarters
- 9830 6Th Street, Suite 103RANCHO CUCAMONGA, CA, United States 91730
- Phone
- 707-714-1088
- Fax
- ---
Executives
- President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
- Michelle Rico
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $9.8K |
|---|---|
Revenue (TTM) | $605.0K |
Shares Outstanding | 49.1M |
Proto Script Pharmaceutical Corp does not pay a dividend. | |
Beta | --- |
EPS | $-0.04 |
Book Value | $0.00 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,298.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
